OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53
出版年份 2016 全文链接
标题
OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-11-30
DOI
10.3389/fphar.2016.00463
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1
- (2015) Ji-chao Wei et al. ACTA PHARMACOLOGICA SINICA
- Redundancy: A Critical Obstacle to Improving Cancer Therapy
- (2015) O. Lavi CANCER RESEARCH
- Reactive oxygen species mediate Terbufos-induced apoptosis in mouse testicular cell lines via the modulation of cell cycle and pro-apoptotic proteins
- (2015) Jui-Hsiang Hung et al. ENVIRONMENTAL TOXICOLOGY
- HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma
- (2015) Manqing Cao et al. TUMOR BIOLOGY
- Systems Biology Strategy Reveals PKCδ is Key for Sensitizing TRAIL-Resistant Human Fibrosarcoma
- (2015) Kentaro Hayashi et al. Frontiers in Immunology
- OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro
- (2014) El-shaimaa A Arafa et al. ACTA PHARMACOLOGICA SINICA
- Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography–tandem mass spectrometry
- (2014) Yicheng Mao et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2
- (2013) Chi-Tan Hu et al. CELLULAR SIGNALLING
- Molecular-targeted agents combination therapy for cancer: Developments and potentials
- (2013) Feifei Li et al. INTERNATIONAL JOURNAL OF CANCER
- Protein kinase C and cancer: what we know and what we do not
- (2013) R Garg et al. ONCOGENE
- OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt–NF-κB and MAPK signaling pathways
- (2013) Hany A. Omar et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The multikinase inhibitor sorafenib induces p53 family-dependent apoptosis in hepatocellular carcinoma
- (2013) S Brost et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells
- (2012) Fukang Xie ONCOLOGY REPORTS
- OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway
- (2011) Li-Yuan Bai et al. BRITISH JOURNAL OF HAEMATOLOGY
- Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib - the role of extracellular signal-regulated kinase counteraction
- (2011) Irena Manov et al. FEBS Journal
- Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma
- (2011) Hany A. Omar et al. HEPATOLOGY
- Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
- (2011) Joan Fernando et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PKCδ regulates Mdm2 independently of p53 in the apoptotic response to DNA damage
- (2011) Hoi Chin Hew et al. MOLECULAR CARCINOGENESIS
- STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development
- (2011) Andre Limnander et al. NATURE IMMUNOLOGY
- Two Faces of Protein Kinase Cδ: The Contrasting Roles of PKCδ in Cell Survival and Cell Death
- (2011) Alakananda Basu et al. TheScientificWorldJOURNAL
- The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer
- (2010) Marianne Farnebo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel inhibitors in development for hepatocellular carcinoma
- (2010) Marcus Alexander Wörns et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
- (2010) Hayato Hikita et al. HEPATOLOGY
- Src, PKCα, and PKCδ are required for αvβ3 integrin-mediated metastatic melanoma invasion
- (2009) Andrew J Putnam et al. Cell Communication and Signaling
- Targeting of the Akt-Nuclear Factor- B Signaling Network by [1-(4-Chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a Novel Indole-3-Carbinol Derivative, in a Mouse Model of Hepatocellular Carcinoma
- (2009) H. A. Omar et al. MOLECULAR PHARMACOLOGY
- FTY720 Induces Apoptosis in Hepatocellular Carcinoma Cells through Activation of Protein Kinase C Signaling
- (2008) J.-H. Hung et al. CANCER RESEARCH
- Phosphorylation of Protein Kinase Cδ on Distinct Tyrosine Residues Induces Sustained Activation of Erk1/2 via Down-regulation of MKP-1
- (2008) Stephanie L. Lomonaco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage
- (2008) X. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now